Personalized omalizumab treatment improves clinical benefit in patients with chronic spontaneous urticaria

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1992-1994
Number of pages	3
Journal	Journal of Allergy and Clinical Immunology
Volume	142
Issue number	6
DOIs	https://doi.org/10.1016/j.jaci.2018.07.032
Publication status	Published - 2018

Research programs

@article{6cffc52a652e4f6c965e09996abf47cb,

title = "Personalized omalizumab treatment improves clinical benefit in patients with chronic spontaneous urticaria",

author = "Tessa Kolk and {van Maaren}, M.S. and {van Doorn}, Martijn",

year = "2018",

doi = "10.1016/j.jaci.2018.07.032",

language = "Undefined/Unknown",

volume = "142",

pages = "1992--1994",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Personalized omalizumab treatment improves clinical benefit in patients with chronic spontaneous urticaria

AU - Kolk, Tessa

AU - van Maaren, M.S.

AU - van Doorn, Martijn

PY - 2018

Y1 - 2018

U2 - 10.1016/j.jaci.2018.07.032

DO - 10.1016/j.jaci.2018.07.032

M3 - Article

C2 - 30144475

SN - 0091-6749

VL - 142

SP - 1992

EP - 1994

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 6

ER -